ATE283697T1 - Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort - Google Patents

Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort

Info

Publication number
ATE283697T1
ATE283697T1 AT01903767T AT01903767T ATE283697T1 AT E283697 T1 ATE283697 T1 AT E283697T1 AT 01903767 T AT01903767 T AT 01903767T AT 01903767 T AT01903767 T AT 01903767T AT E283697 T1 ATE283697 T1 AT E283697T1
Authority
AT
Austria
Prior art keywords
praebiotic
boosting
adjuvant
immune response
carbohydrate formulation
Prior art date
Application number
AT01903767T
Other languages
English (en)
Inventor
Ferdinand Haschke
Anne-Lise Carrie
Zdenek Kratky
Harriet Link-Amster
Florence Rochat
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE283697T1 publication Critical patent/ATE283697T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Grain Derivatives (AREA)
AT01903767T 2000-03-01 2001-02-14 Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort ATE283697T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200735 2000-03-01
PCT/EP2001/001627 WO2001064225A1 (en) 2000-03-01 2001-02-14 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Publications (1)

Publication Number Publication Date
ATE283697T1 true ATE283697T1 (de) 2004-12-15

Family

ID=8171132

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01903767T ATE283697T1 (de) 2000-03-01 2001-02-14 Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort

Country Status (21)

Country Link
US (2) US20030040492A1 (de)
EP (1) EP1261355B1 (de)
JP (1) JP4838477B2 (de)
KR (1) KR20020081375A (de)
CN (1) CN1243551C (de)
AR (1) AR027968A1 (de)
AT (1) ATE283697T1 (de)
AU (2) AU2001231746C1 (de)
BR (1) BR0108828A (de)
CA (1) CA2400969C (de)
DE (1) DE60107544T2 (de)
ES (1) ES2232591T3 (de)
HU (1) HUP0204546A3 (de)
IL (1) IL151280A0 (de)
MX (1) MXPA02008447A (de)
NO (1) NO20024011L (de)
PL (1) PL365136A1 (de)
PT (1) PT1261355E (de)
UA (1) UA73763C2 (de)
WO (1) WO2001064225A1 (de)
ZA (1) ZA200207849B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6319252B1 (en) 1999-07-23 2001-11-20 Mcdevitt Dennis System and method for attaching soft tissue to bone
KR20020043078A (ko) * 2000-12-01 2002-06-08 한인규 올리고당이 포함된 복합생균제
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
US20050118299A1 (en) * 2003-12-01 2005-06-02 The Iams Company Companion animal compositions comprising short chain oligofructose
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8287931B2 (en) 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
EP2073643A2 (de) * 2006-10-18 2009-07-01 DSMIP Assets B.V. Verkapselung von hitze- und feuchtigkeitsempfindlichen substanzen
DE102007008664B4 (de) * 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
EP2187756A1 (de) * 2007-08-24 2010-05-26 Barry Callebaut AG Verfahren und hiermit hergestelltes konfektprodukt
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
SI2285387T1 (sl) 2008-06-13 2016-02-29 N.V. Nutricia Prehrana za preprečevanje infekcij
EP2293802A4 (de) * 2008-06-25 2011-11-09 Ritter Pharmaceuticals Inc Lactosezusammensetzungen mit reduziertem lactosegehalt
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
EP2400839B1 (de) 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und verwendungsverfahren dafür
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
CN102497868A (zh) 2009-07-15 2012-06-13 N.V.努特里奇亚 用于刺激免疫系统的不可消化低聚糖的混合物
PL2453901T3 (pl) 2009-07-15 2015-03-31 Nutricia Nv Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych
WO2011060123A1 (en) 2009-11-12 2011-05-19 Nestec S.A. Nutritional composition for promoting gut microbiota balance and health
EP3202406A1 (de) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und deren verwendungen
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
WO2013149017A1 (en) * 2012-03-28 2013-10-03 Kansas State University Research Foundation Vaccine adjuvant
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
CN103330935A (zh) * 2013-06-17 2013-10-02 中山大学 果糖作为疫苗佐剂的应用
EP3079502A1 (de) 2013-11-04 2016-10-19 N.V. Nutricia Fermentierte formel mit nichtverdaulichen oligosacchariden
JP6637587B2 (ja) * 2015-08-04 2020-01-29 ズートツッカー アーゲー 副鼻腔炎に対するイヌリンの予防的使用
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
EP3679057A1 (de) * 2017-09-08 2020-07-15 Evelo Biosciences, Inc. Extrazelluläre vesikel aus prevotella
EP3678693A1 (de) 2017-09-08 2020-07-15 Evelo Biosciences, Inc. Bakterielle extrazelluläre vesikel
JP7469037B2 (ja) * 2019-02-28 2024-04-16 森永乳業株式会社 発酵乳
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用
CN113876935B (zh) * 2021-10-19 2025-11-04 深圳市红瑞生物科技有限公司 一种治疗宠物肠道疾病的组合物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3689071T2 (de) 1985-10-31 1994-02-10 Univ Australian Immunheilbehandlung.
US5422346A (en) 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
DE4341780A1 (de) * 1993-12-08 1995-06-14 Suedzucker Ag Hydrierte Fructooligosaccharide
DE69520528T2 (de) * 1994-06-14 2001-09-27 Raffinerie Tirlemontoise, S.A. Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel
ATE169456T1 (de) * 1996-12-23 1998-08-15 Sitia Yomo Spa Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome

Also Published As

Publication number Publication date
JP4838477B2 (ja) 2011-12-14
AU2001231746C1 (en) 2005-10-06
US7101553B2 (en) 2006-09-05
AR027968A1 (es) 2003-04-16
BR0108828A (pt) 2002-12-10
UA73763C2 (en) 2005-09-15
ZA200207849B (en) 2003-12-30
NO20024011D0 (no) 2002-08-22
AU2001231746B2 (en) 2004-12-23
CN1243551C (zh) 2006-03-01
PT1261355E (pt) 2005-02-28
JP2003533438A (ja) 2003-11-11
AU3174601A (en) 2001-09-12
HUP0204546A3 (en) 2003-10-28
MXPA02008447A (es) 2002-12-13
PL365136A1 (en) 2004-12-27
EP1261355A1 (de) 2002-12-04
NO20024011L (no) 2002-08-22
CA2400969A1 (en) 2001-09-07
US20030040492A1 (en) 2003-02-27
IL151280A0 (en) 2003-04-10
WO2001064225A1 (en) 2001-09-07
ES2232591T3 (es) 2005-06-01
KR20020081375A (ko) 2002-10-26
HUP0204546A2 (en) 2003-05-28
EP1261355B1 (de) 2004-12-01
CA2400969C (en) 2011-04-19
HK1051650A1 (en) 2003-08-15
DE60107544T2 (de) 2005-12-15
US20040191234A1 (en) 2004-09-30
CN1422158A (zh) 2003-06-04
DE60107544D1 (de) 2005-01-05

Similar Documents

Publication Publication Date Title
ATE283697T1 (de) Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort
FI20011593L (fi) Immunologinen adjuvanttiyhdiste
DE69907420D1 (de) Zyklische pro-duftverbindungen die die geruchrohstoffalkohol freisetzungsstufe ändern
DE69114526D1 (de) Polysiloxankontaktklebstoffzusammensetzungen.
DK1265633T3 (da) Vaccineadjuvans
ITBO990289A0 (it) Apparecchiatura per la realizzazione di cornici rettangolari .
FI920430L (fi) Benzyloxifenylderivator.
IT1307196B1 (it) Dispositivo di comando per idropulitrici o simili
ATE94417T1 (de) Chip fuer spieltische.
GB2364642B (en) Compositions for enhancing the immune response
FI20010247A0 (fi) Imulaite
ITMI20001695A0 (it) Procedimento per la preparazione di composizioni organico-sili-coniche.
FI980531A0 (fi) Suganordning
DE60017345D1 (de) Tintenstrahlaufzeichnungselement
NO20032086L (no) Adjuvans kombinasjonsformuleringer
IT1299630B1 (it) Dispositivo di connessione per la connessione di due corpi
DE69201298D1 (de) Klebemittelzusammensetzungen.
NO20010238D0 (no) Systemer for presentasjon på overflaten til metanotrofe bakterier
ITBO990458A0 (it) Apparecchiatura per la realizzazione di cornici rettangolari .
DK1261355T3 (da) Carbohydratformulering (præbiotisk adjuvans) til forstærkning af immunresponset
IT221500Z2 (it) Dispositivo di presa per cassetti espositori o simili
ATE395352T1 (de) 17.alpha.-hydroxy-14.beta.-steroide mit hormonaler wirkung
ITMI20001600A1 (it) Procedimento per la preparazione di 5-amino-4-alo-3-alchil isossazoli.
ES1016586Y (es) Nicho funerario.
DE60237252D1 (de) Bildaufzeichnungsgerät

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1261355

Country of ref document: EP

REN Ceased due to non-payment of the annual fee